AAAAAA
Results:
1-21
|
Results: 21
Authors:
HUBBLE JP
KURTH JH
GLATT SL
KURTH MC
SCHELLENBERG GD
HASSANEIN RES
LIEBERMAN A
KOLLER WC
Citation: Jp. Hubble et al., GENE-TOXIN INTERACTION AS A PUTATIVE RISK FACTOR FOR PARKINSONS-DISEASE WITH DEMENTIA, Neuroepidemiology, 17(2), 1998, pp. 96-104
Authors:
KURTH MC
Citation: Mc. Kurth, USING LIQUID LEVODOPA IN THE TREATMENT OF PARKINSONS-DISEASE - A PRACTICAL GUIDE, Drugs & aging, 10(5), 1997, pp. 332-340
Authors:
CHARLES PD
DAVIS TL
SAINTHILAIRE MH
TROSCH RM
LEWITT P
KURTH MC
PEDDER S
DORFLINGER E
Citation: Pd. Charles et al., A 6-MONTH OPEN-LABEL TRIAL OF TOLCAPONE IN PARKINSONS-DISEASE, Annals of neurology, 42(3), 1997, pp. 64-64
Authors:
KURTH JH
EGGERSSEDLET B
LIEBERMAN AN
KURTH MC
Citation: Jh. Kurth et al., NITRIC-OXIDE SYNTHASE GENE POLYMORPHISMS AND PARKINSONS-DISEASE, Neurology, 48(3), 1997, pp. 3098-3098
Authors:
KURTH MC
KOPYOV OV
JACQUES DB
CAVINESS JN
DUMA M
EAGLE S
LIEBERMAN N
Citation: Mc. Kurth et al., SAFETY OF FETAL TISSUE-TRANSPLANTATION FOR HUNTINGTONS-DISEASE, Neurology, 48(3), 1997, pp. 12004-12004
Authors:
KURTH MC
ADLER CH
STHILAIRE M
SINGER C
WATERS C
LEWITT P
CHERNIK DA
DORFLINGER EE
YOO K
LIEBERMAN AN
BREWER M
SAINTHILAIRE M
PERY LM
THOMAS C
TURPIN L
OBRIEN CF
SEEBERGER LC
DUNCAN KL
CAVINESS JN
DOUGLAS M
WHEELER K
RILEY D
RAINEY P
TANNER CM
KELKER K
LEWIS P
TROSCH RM
MISTURA KL
MONTGOMERY EB
LINDSEY B
WEINER W
SHULMAN LM
SHELDON C
WATERS CH
WELSH M
TRUGMAN JM
LANDOW ER
PEDDER SCJ
SHIMON GS
MAGNI G
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE EXPERIENCING MOTOR FLUCTUATIONS - A MULTICENTER, DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED TRIAL, Neurology, 48(1), 1997, pp. 81-87
Authors:
WATERS CH
KURTH MC
SHULMAN L
BAILEY P
SHALE H
DORFLINGER E
YOO K
SHIMOUN G
PEDDER S
Citation: Ch. Waters et al., EVALUATION OF THE EFFICACY AND SAFETY OF TOLCAPONE (TASMAR) IN PARKINSONS-DISEASE PATIENTS WITH A STABLE RESPONSE TO LEVODOPA, Neurology, 46(2), 1996, pp. 4006-4006
Authors:
KHATTER AS
KURTH MC
MERROTO MA
BREWER MA
MEHAGIAN M
LIEBERMAN AN
Citation: As. Khatter et al., CONTINUING FOLLOW-UP OF TREMOR AND PARKINSONS-DISEASE IN A RETIREMENTCOMMUNITY - PHASE-II, Neurology, 46(2), 1996, pp. 5133-5133
Authors:
KURTH MC
KOPYOV O
JACQUES DB
Citation: Mc. Kurth et al., IMPROVEMENT IN MOTOR FUNCTION AFTER FETAL TRANSPLANTATION IN A PATIENT WITH HUNTINGTONS-DISEASE, Neurology, 46(2), 1996, pp. 22006-22006
Authors:
BREWER MA
KURTH MC
IMKE SC
LIEBERMAN AN
Citation: Ma. Brewer et al., SAFETY AND EFFECTIVENESS OF CLOZAPINE FOR PARKINSONIAN-PATIENTS WITH PSYCHOSIS, Neurology, 45(4), 1995, pp. 252-252
Authors:
KURTH MC
ADLER CH
STHILAIRE M
SINGER C
WATERS C
CHERNIK DA
DORFLINGER E
YOO K
DAVIS T
HOEHN M
LEWITT P
MONTGOMERY E
MUENTER M
TANNER C
TRUGMAN J
Citation: Mc. Kurth et al., TOLCAPONE IMPROVES MOTOR FUNCTION AND REDUCES LEVODOPA REQUIREMENT INPATIENTS WITH PARKINSONS-DISEASE (PD) EXPERIENCING END-OF-DOSE MOTOR FLUCTUATIONS, Neurology, 45(4), 1995, pp. 275-276
Authors:
KURTH JH
HUBBLE JP
EGGERS EA
KURTH MC
KOLLER WC
LIEBERMAN AN
Citation: Jh. Kurth et al., LACK OF ASSOCIATION OF CYP2D6 AND MAO-B ALLELES WITH PARKINSONS-DISEASE IN A KANSAS COHORT, Neurology, 45(4), 1995, pp. 429-429
Authors:
EGGERS B
KURTH MC
KURTH JH
Citation: B. Eggers et al., ALLELIC FREQUENCIES OF DOPAMINE-RECEPTORS DRD1 AND DRD2 IN PARKINSONS-DISEASE POPULATIONS, American journal of human genetics, 57(4), 1995, pp. 925-925
Authors:
HUBBLE JP
GLATT SL
KURTH MC
SCHELLENBERG GD
HASSANEIN RES
LIEBERMAN AN
KOLLER WC
KURTH JH
Citation: Jp. Hubble et al., CYTOCHROME-P-450 GENOTYPE AND PESTICIDE EXPOSURE AS PREDICTORS OF PARKINSONS-DISEASE DEMENTIA, American journal of human genetics, 57(4), 1995, pp. 1962-1962
Authors:
KURTH MC
KURTH JH
HUBBLE JP
SLIGER L
EGGERS B
LIEBERMAN AN
KOLLER WC
Citation: Mc. Kurth et al., GENETIC-EVIDENCE OF DIFFERENCES IN PARKINSONS-DISEASE SUSCEPTIBILITY BY CYP2D6 AND MAOB GENOTYPES, American journal of human genetics, 57(4), 1995, pp. 1964-1964
Authors:
KURTH MC
EGGERS EA
KURTH JH
Citation: Mc. Kurth et al., IN SEARCH OF SUPER OXIDE DISMUTASE (SOD1) GENE POLYMORPHISMS IN PARKINSONS-DISEASE (PD), Neurology, 44(4), 1994, pp. 10000270-10000270
Authors:
HARTLEY DM
KURTH MC
BJERKNESS L
WEISS JH
CHOI DW
Citation: Dm. Hartley et al., GLUTAMATE RECEPTOR INDUCED CA-2-CULTURE CORRELATES WITH SUBSEQUENT NEURONAL DEGENERATION((45) ACCUMULATION IN CORTICAL CELL), The Journal of neuroscience, 13(5), 1993, pp. 1993-2000
Authors:
KURTH MC
KURTH JH
Citation: Mc. Kurth et Jh. Kurth, VARIANT CYTOCHROME-P450 CYP2D6 ALLELIC FREQUENCIES IN PARKINSONS-DISEASE, American journal of medical genetics, 48(3), 1993, pp. 166-168
Authors:
KURTH MC
TETRUD JW
TANNER CM
IRWIN I
STEBBINS GT
GOETZ CG
LANGSTON JW
Citation: Mc. Kurth et al., DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER STUDY OF DUODENAL INFUSION OF LEVODOPA CARBIDOPA IN PARKINSONS-DISEASE PATIENTS WITH ON-OFF FLUCTUATIONS, Neurology, 43(9), 1993, pp. 1698-1703
Authors:
KURTH MC
TETRUD JW
IRWIN I
LYNESS WH
LANGSTON JW
Citation: Mc. Kurth et al., ORAL LEVODOPA CARDIBOPA SOLUTION VERSUS TABLETS IN PARKINSONS PATIENTS WITH SEVERE FLUCTUATIONS - A PILOT-STUDY, Neurology, 43(5), 1993, pp. 1036-1039
Authors:
KURTH MC
DIEDERICH N
IRWIN I
TETRUD JW
TANNER CM
GOETZ CG
LANGSTON JW
Citation: Mc. Kurth et al., 2-YEAR FOLLOW-UP OF PARKINSONS-DISEASE PATIENTS ON DAILY DUODENAL INFUSION OF LEVODOPA, Neurology, 43(4), 1993, pp. 348-348
Risultati:
1-21
|